Fidelity Select Biotechnology Portfolio (FBIOX) - Health fund with $5.93 Billion in assets. The fund allocates 56.99% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is ABBVIE INC at 13.22% of total assets. This is followed by AMGEN INC (8.34%) and KRYSTAL BIOTECH INC (9.30%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| ABBVIE INC | 13.22% | - | - |
| AMGEN INC | 8.34% | - | - |
| KRYSTAL BIOTECH INC | 9.30% | - | - |
| Fidelity Securities Lending Cash Central Fund | 2.55% | - | - |
| REGENERON PHARMACEUTICALS INC | 3.02% | - | - |
| VERTEX PHARMACEUTICALS INC | 4.56% | - | - |
| ALNYLAM PHARMACEUTICALS INC | 3.09% | - | - |
| GILEAD SCIENCES INC | 8.77% | - | - |
| UCB SA | 2.17% | - | - |
| ZEALAND PHARMA A/S | 1.97% | - | - |
| ARGENX SE SPONSORED ADR | 2.86% | - | - |
| ASCENDIS PHARMA AS SPON ADR | 2.44% | - | - |
| INSMED INC | 2.26% | - | - |
| PRAXIS PRECISION MEDICINES INC | 2.46% | - | - |